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Abstract
Introduction. Somatic chromosomal rearrangements that occur in infertile males are thought to be one of the 
major genetic factors influencing male infertility. The objective of this retrospective study was to evaluate sperm 
parameters in a group of patients with balanced translocations. 
Material and methods. We analyzed semen of 84 balanced somatic translocation carriers [35 Robertsonian 
translocation (RT group) and 49 reciprocal translocation (RCT group)] and 57 men with normal karyotype 
(control group). 
Semen samples were evaluated for sperm concentration, its motion parameters and vitality, round cell number 
(CASA) and DNA fragmentation index (TUNEL). Cytogenetic evaluation was also performed for each study 
participant.
Results. Sperm concentrations were lower when comparing the RT group to the control (p < 0.001) and RCT 
groups (p < 0.05). Occurrence of abnormal sperm concentration was more common among RT carriers (74.3%) 
than in the other groups (42.9% in RCT group and 28.1% in control group). The sperm progressive motility and 
vitality in RT carriers (21.53% and 62.17%) were lower than in control group (39.77% and 77.47%, p < 0.001, 
respectively) and RCT carriers (31.47% and 76.17%, p < 0.001, respectively). The RCT carriers and the control 
group did not differ in regard to sperm concentration, progressive sperm motility, motility grade D and sperm 
vitality. There were no significant differences in DNA fragmentation in carriers of both studied structural chro-
mosomal rearrangements in comparison to subjects with normal karyotype. 
Conclusions. RT carriers had significantly lower semen parameters in comparison to not only the subjects with 
normal karyotypes but also the RCT carriers. (Folia Histochemica et Cytobiologica 2015, Vol. 53, No. 4, 314–321)
Key words: Robertsonian translocation; reciprocal translocation; balanced chromosomal rearrangements; 
sperm parameters; DNA fragmentation
Introduction
It is estimated that approximately 15% of couples 
are infertile. Among the various causes of infertility, 
male factor is responsible for approximately 30–50% 
of cases. Nowadays, male infertility is considered as 
a multifactorial disease and identification of its etiology 
in an individual is critical for effective treatment. 
Chromosomal rearrangements are thought to ac-
count for 2–8% of male factor infertility [1]. Genetic 
changes influence fertility as they may affect a variety 
of processes including hormonal status, spermatogen-
esis, and sperm quality [2]. Genetic defects may cause 
the dysfunction of the hypothalamo-gonadal axis or 
affect development of male gonads and urogenital 
tract. Moreover, they may stop germ cell maturation 
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or lead to the production of defective spermatozoa 
[3]. Effective chromosome segregation is essential for 
premeiotic divisions and meiosis, as sperm aneuploidy 
can arise at this stage due to segregation errors [4]. 
Understanding of male factor infertility requires a de-
tailed knowledge of the biological and genetic factors 
needed for normal sperm development and function. 
Chromosomal aberrations have been postulated 
to be one of the major genetic factors responsible 
for occurrences of male infertility [5, 6]. Somatic 
chromosomal rearrangements are found in infertile 
men approximately 10 times more often than in the 
general population [7]. The prevalence of balanced 
autosomal translocations in the population of in-
fertile men has been reported to be in the range of 
1.6–6.6% [8–10]. Reciprocal translocations (RCT) 
are the replacement of genetic material between 
two or more chromosomes that does not result in 
the loss of genetic material [5]. A different kind 
of chromosomal rearrangement are Robertsonian 
translocations (RT) which involve the connection 
of two acrocentric chromosomes, in which two 
long (q) arms of each chromosome join to form 
a new chromosome and two short (p) arms are lost. 
This causes a condition of 45,XY but is considered 
balanced given that the lost short arms contain re-
petitive genetic material.
Balanced translocations (RCT and RT) are the 
most common chromosomal structural rearrange-
ments identified in humans which do not usually cause 
phenotypic consequences, apart from possibility of 
infertility. Balanced translocation carriers may create 
unbalanced gametes leading to an increased risk of 
recurrent miscarriages or having children with con-
genital anomalies [11].
Sperm concentration is currently the most com-
monly examined parameter in relation to the preva-
lence of chromosomal rearrangements in infertile 
men. However, there have been no systematic studies 
of all sperm parameters including not only sperm 
concentration or motility but also vitality and DNA 
fragmentation in translocation carriers. Thus, the aim 
of this study has been to evaluate sperm parameters in 
a group of patients with balanced translocations (both 
RCT and RT) and compare them to the sperm para-
meters of unaffected donors with normal karyotypes.
Material and methods
Study population. The study protocol has been approved 
by the Institutional Review Board. All donors gave their 
informed consent for semen analysis and karyotyping. 
This is a retrospective assessment of the data of patients 
treated between January 2009 and November 2014 at the 
INVICTA Fertility Clinic (INVICTA, Gdansk, Poland). The 
study group included 84 men with balanced translocations 
(49 RCT and 35 RT carriers). The mean age of participants 
was 34.65 ± 4.72 for RCT, 35.03 ± 4.49 for RT carriers, 
and 36.37 ± 4.16 years for control subjects (p > 0.05). No 
statistically significant differences were found in terms of 
sexual abstinence. Round cell concentrations did not differ 
among the groups either. 
Patients affected by other factors that could influence 
fertility (i.e. microdeletion of the AZF region, excessive 
alcohol intake, chronic or hallucinatory drug use, systemic 
disease, hereditary disorders) were excluded from the study. 
Fifty seven men with normal karyotype and not meeting 
the exclusion criteria were randomly selected from among 
partners of women diagnosed with tubal factor, served as 
a control group. Since it is widely accepted [12] that 35% of the 
causes of infertility are female-related, 35% male-related, in 
25% of the cases problem affects both partners, and in 5% of 
cases the cause remains unknown. We decided to use as the 
control group partners of women with a confirmed female 
factor, in order to get a population distribution similar to that 
of male factor infertility.
Semen analysis. Analysis of fresh semen samples were 
performed at the INVICTA Medical Laboratories in 
Gdansk, according to the guidelines of the World Health 
Organization [12]. Semen samples were collected by mas-
turbation after 2–7 days of sexual abstinence. Samples 
were liquefied at room temperature for 60 minutes before 
analysis. The volume, pH, color and viscosity were deter-
mined for each sample. The eosin test was performed to 
detect viable spermatozoa. Sperm counts and percentage 
motility were measured by computer assisted sperm analysis 
(CASA) system using the IVOS Hamilton Thorn Analyzer 
(Hamilton Thorne Inc., Beverly, Massachusetts, USA). At 
least one sperm analysis was recorded for all patients from 
all groups included in the study. In cases of patients with 
multiple analyses performed only data from the first sperm 
analysis were used.
Semen status was classified as follows: azoospermia 
(defined as the lack of sperm in the ejaculate) and severe 
oligozoospermia (sperm concentration < 5 million/mL), 
oligozoospermia (sperm concentration 5–15 million/mL), 
normospermia (sperm concentration > 15 million/mL), 
cryptozoospermia (spermatozoa absent from fresh prepa-
rations but observed in a centrifuged pellet). Sperm motility 
was classified as: A — rapid progressive motility; B — slow 
progressive motility; C — non progressive motility; D — im- 
motility. 
TUNEL assay. Due to the retrospective design of the study 
only one test was used for the evaluation of sperm DNA 
fragmentation. It was evaluated using a TUNEL assay kit 
(APO-DIRECT™ Kit, BD Biosciences Pharmingen, San 
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Diego, California, USA) in compliance with the manufactur-
er’s instructions and specifications, with minor modifications. 
Briefly, spermatozoa were washed in phosphate-buffered 
saline (PBS) and placed onto the slide. Air-dried slides were 
fixed with 4% paraformaldehyde at room temperature. For 
permeabilization, the cells were incubated for 15 min at 4–8°C 
with 2% Triton X-100. Labeling, preceded by washing with 
Wash Buffer provided by the manufacturer, were performed 
by incubation for 1 hour in the dark at 37°C with labeling 
solutions [terminal deoxytransferase (TdT) enzyme, TdT re-
action buffer, fluorescein isothiocynate-tagged deoxyuridine 
triphosphate nucleotides (FITC-dUTP), and distilled water]. 
After labeling, slides were rinsed in Rinsing Buffer and then 
counterstained with DAPI (4,6 diamidino-2-phenylindole). 
Each spermatozoon was considered to have either normal 
(blue nuclear fluorescence) or fragmented (partial or total 
green fluorescence) DNA. Sperm DNA fragmentation index 
was established as a final percentage of spermatozoa with 
fragmented DNA. The positive and negative control cells 
were provided in the APPDIRECT™ Kit (BD Biosciences 
Pharmingen, San Diego, California, USA). At least 300–400 
cells in each sample were counted with the use of objective 
UPlanFl 60x NA 1.25 on Olympus BX62 epifluorescence 
microscope (Olympus, Tokyo, Japan). Each spermatozoon 
was photographed using CCD camera (Pixera Pro 600ES) 
and pictures were archived (Viewfinder ver. 3.0.1).
Cytogenetic evaluation. Cytogenetic examinations were 
performed on metaphases obtained from peripheral 
blood lymphocyte cultures using standard procedure [13]. 
Briefly, the 0.5 mL heparinized peripheral blood samples 
were cultured at 37°C for 72 h in RPMI-1640 Medium 
(Sigma-Aldrich, USA), supplemented with fetal bovine 
serum, (PAN-Biotech, Germany) and Lectins LF-7 (IBSS 
BIOMED SA, Poland). Culture was terminated 30 min 
after adding 10 μg/mL colchicines (Gibco, Life Technolo-
gies, Carlsbad, California, USA). Hypotension, fixation, 
trypsynization and Wright staining procedure were used 
to visualize G-banded chromosomes. Karyotypes were 
established at approximately 450–550 bands resolution. At 
least 15 metaphases were analyzed for each patient. Images 
were captured using CytoVision software (ver. 3.9), and 
the karyotypes were designated according to International 
System for Chromosome Nomenclature (ISCN; 2013). 
Chromosome polymorphisms and variants or fragile sites 
were not considered in the description of abnormalities.
Statistical analysis. Statistical analyses were performed us-
ing GraphPad Prism (ver. 5.1, Graphpad Software Inc., San 
Diego, California, USA). Kruskal-Wallis test with post-hoc 
Dunn’s Bonferroni test was used for comparisons among all 
analyzed groups and to test for significance. Additionally, the 
chi-square test was used to compare differences among the 
studied groups. Statistical significance was defined as p < 0.05.
Results
Characteristics of patients, semen and sperm para-
meters of translocations carriers and the control group 
are shown in Table 1. 
Results of lymphocyte karyotyping analysis among 
balanced translocation carriers are presented as 
Supplementary data. Examples of karyograms of the 
RCT and RT patients and DNA fragmentation of 
spermatozoa are presented in Figure 1.
No statistically significant differences were found 
between the study groups in terms of age, sexual absti-
nence, sperm volume, round cells concentration, sperm 
motility grade C and sperm DNA fragmentation index.
There were no significant differences in sperm 
concentration between the RCT carriers and the 
control group. However, diminished number of sper-
matozoa were observed in semen collected from RT 
carriers in comparison to the control group (p < 0.001; 
Figure 2A). Lower sperm concentrations were also 
observed for RT in comparison to RCT carriers 
(p < 0.05; Figure 2A). 
In the course of our research, we found normal 
semen parameters in 25.7% of RT and 57.1% of RCT 
carriers (Figure 3). These rates were lower than in con-
trol subjects (71.9%). Occurrences of abnormal sperm 
concentration were more common among carriers of 
a chromosomal rearrangement (42.9% in RCT group 
and 74.3% in the RT group; Table 1) than among 
subjects with normal karyotype (28.1%; Table 1). 
We found statistically significant differences in regard 
to occurrences of abnormal sperm concentration when 
comparing RT carriers to the control group (p < 0.001) 
and to the RCT group (p < 0.05). Comparison of the 
RCT carriers group versus the control group yielded 
no significant difference.
Sperm vitality was reduced in samples from RT 
carriers in comparison to the control (p < 0.001) 
and RCT (p < 0.001) carriers groups (Figure 2B). 
There were no statistical differences between RCT 
and control group.
Progressive sperm motility (grade A + B) was 
significantly lower (p < 0.001; Figure 2C), while 
sperm motility grade D was significantly higher 
(p < 0.001; Figure 2D) for the group of RT carriers 
in comparison to the control subjects. No significant 
differences in progressive sperm motility and immotile 
sperm were observed between the RCT carriers and 
control group. 
Discussion
We present a study of the semen of a large group 
of balanced somatic translocation carriers and men 
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with normal karyotype to establish sperm parameters. 
We compared retrospectively results obtained from 
analysis of the semen samples which were not frozen 
before tests and were categorized in a homogeneous 
groups of the RCT and RT translocation carriers. 
The use of semen samples from donors with normal 
karyotype who were partners of the female with 
established etiology of infertility, provided us with 
a reliable control group. 
Probability of detecting a chromosomal rearrange-
ments in a patient’s karyotype is negatively correlated 
to the sperm concentration [14–17]. Indeed, in this 
study, we observed lowered sperm concentration in 
the RT carrier group, but not in the RCT group in 
comparison to the control subjects. Significantly lower 
concentrations of sperm in semen of RT translocation 
carriers in comparison to ejaculated samples of fertile 
donors were also observed by other authors [18]. The 
lower number of sperm in semen of RT carriers can 
be the result of spermatogenesis impairment caused 
by the process of segregation and improper gene ex-
pression during gamete formation [19, 20]. Activation 
of the process of apoptosis which allowed, at least 
partially, for exclusion of cells with chromosomal 
rearrangements [21] during spermiogenesis [18], can 
also explain this phenomenon.
In our study a number of RT (25.7%) and RCT 
(57.1%) carriers had sperm parameters within normal 
ranges. However, those parameters are lower than the 
rates mentioned in studies by Vozdova et al. (30.8% 
of RT and 59.5% of RCT translocation carriers) [22] 
and the data presented by other authors [19]. This 
suggests that autosomal rearrangement of the kary-
otype does not always lead to severe oligozoospermia 
or azoospermia as do sex chromosome aberrations [5]. 
Chandley et al. [23] showed a reduced proportion 
of spermatids and spermatozoa on testicular biopsy in 
subfertile balanced translocations carriers. Balanced, 
structural chromosome aberrations seldom result in 
azoospermia [20, 24]. The most often reported pheno-
types for balanced translocation carriers usually vary 
from severe oligozoospermia to normozoospermia [2, 
Table 1. Patients characteristics, semen and sperm parameters of balanced translocation carriers and control subjects with 
normal karyotype
Normal karyotype  




(RCT; n = 49)
Robertsonian  
translocations  
(RT; n = 35)
p*
Age (years) 36.37 ± 4.16 34.65 ± 4.72 35.03 ± 4.49 0.059
Sexual abstinence (day) 5.29 ± 2.82 4.63 ± 4.74 4.52 ± 1.39 0.717
Seminal volume [mL] 3.75 ± 1.77 3.38 ± 1.80 3.89 ± 2.09 0.368
Sperm concentration [million/mL] 49.87 ± 44.58b 35.23 ± 35.51b 15.22 ± 25.83a < 0.001
Normozoospermia (n = 78)  
(> 15 million/mL)
71.9% (41) 57.1% (28) 25.7% (9)
0.001
Abnormal sperm concentration (n = 63)  
(< 15 million/mL)
28.1% (16) 42.9% (21) 74.3% (26)
Azoospermia (n = 4) 0% (0) 6.1% (3) 2.9% (1)
Cryptozoospermia (n = 6) 1.8% (1) 4.1% (2) 8.6% (3)
Severe oligozoospermia (< 5 million/mL) (n = 24) 7.0% (4) 18.4% (9) 31.4% (11)
Oligozoospermia (5–15 million/mL) (n = 29) 19.3% (11) 14.3% (7) 31.4% (11)
Sperm motility (%)
A + B 39.77 ± 19.40b 32.47 ± 21.03ab 21.53 ± 18.37a < 0.001
C 12.88 ± 8.60 12.33 ± 9.07 12.67 ± 10.37 0.912
D 47.34 ± 21.76a 55.23 ± 25.25ab 66.23 ± 20.28b 0.002
Sperm vitality: live (%) 77.47 ± 13.03b 76.17 ± 15.84b 62.17 ± 18.78a < 0.001
Round cell [million/mL] 3.42 ± 5.71 1.89 ± 1.20 1.98 ± 1.44 0.555
DNA fragmentation index (%) 13.86 ± 5.49 12.47 ± 6.34 15.78 ± 7.06 0.194
Data are mean ± SD or prevalence, n is given in parentheses. *Comparison between groups was performed by Kruskal-Wallis test for continuous 
data and by the c2 test for categorical data. Different letters (a,b) indicate statistically significant differences (performed by post-hoc Dunn’s Bon-
ferroni test) within the RCT, RT and control groups. DNA fragmentation was determined by the TUNEL technique as described in Material and 
methods
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Figure 1. Exemplary lymphocytic karyogram of the patients carrying RCT (46,XY,t(4;10)(q21;p11.2) (A), and RT 
(45,XY,der(13;14)(q10;q10)) (C) translocations. TUNEL analysis of spermatozoa of the same patients carrying RCT (B) 
and RT (D) translocations. Magnification: karyogram — ×1000; TUNEL analysis — ×630
A B
C D
20, 25]. Nonetheless, in our study we found statistically 
significant difference between sperm concentration 
and occurrence of chromosomal rearrangements. This 
parameter in RT translocation carriers was lower than 
in the other groups. At the same time, most aberra-
tions are found in azoospermic and severely oligozo-
ospermic men [9] what is partially in agreement with 
the results of our study. However, other authors did 
observe such high correlation in subgroups of infertile 
men [26, 27]. 
In our study, we showed decreased progressive 
sperm motility and increased sperm immotility in 
RT carriers. It was suggested that unbalanced chro-
mosomal status has no impact on the motility of the 
sperm [28]. Other authors presented results showing 
no differences in terms of this sperm parameter be-
tween men with normal and abnormal karyotypes [29, 
30]. On the other hand, comparisons of RT carriers 
and control donors revealed decreased sperm motility 
in the group of patients carrying RT [18, 19, 22] for 
those with normal [19] and abnormal semen param-
eters [22]. Additionally, more recent data show only 
4% progressive motility in 45,XY,t(14;14)(q10;q10) 
patients [31] and 8–17% progressive motility in 
45,XY,t(14;22) patients [32]. Fadlalla et al. [24] pre-
sented decreased sperm motility in 45,XY,der(13;14)
(q11;p11) donors, while Morel et al. [33] showed se-
men parameters of three 45,XY,der(13;14)(q10;q10) 
patients whose sperm motility were significantly re-
duced. In our studies 24 out of 35 RT carriers were 
45,XY,der(13;14)(q10;q10). However, we did not find 
difference between 45,XY,der(13;14) versus others 
RT carriers (data not shown). Moreover, the influence 
of freezing on diminished sperm motility [34] can be 
excluded, as we retrospectively considered only the 
results of analyses carried out on a fresh semen samples.
Results of our investigation showed that in all of 
studied group sperm vitality was not lower than 58%, 
what is the WHO standard and what is in agreement 
with the data presented by others [32, 35]. However, 
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Figure 3. Relative frequency of distribution of occurrences of normal/abnormal sperm concentration in control, RCT  
and RT groups. Values are expressed as % of study groups
Figure 2. Characteristics of sperm of control, RCT and RT carriers. Concentration (A), vitality (B), progressive motility 
grade A + B (C), motility grade D (D). Different letters indicate statistically significant differences (performed by  
post-hoc Dunn’s Bonferroni test) within the RCT, RT and control groups
A B
C D
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our study additionally presented that in RT carriers 
these values were reduced in comparison to both 
control and RCT group. As far as we know until 
now, there has not been any publication presenting 
such data.
Sperm DNA fragmentation designated as DNA 
fragmentation index reflects apoptotic process which 
takes place in a cell. The DNA damage rate, which 
may be affected by age [36] is significantly higher in 
the ejaculated sperm of translocation carriers than 
in control subjects [18, 37, 38]. Moreover, DNA 
fragmentation index is higher in spermatozoa of RT 
carriers with chromosomally unbalanced content in 
comparison to those who have normal or balanced 
ejaculated spermatozoa [21]. Thus, apoptosis seems 
to be quite common for spermatozoa of translocation 
carriers as it can function as a mechanism of selection 
of abnormal spermatozoa. In male germ cells, mei-
otic spindle check-point mechanism, as a guard of 
proper meiosis, is present. If aberrant meiosis occurs, 
activation of apoptosis takes place. Moreover, oxida-
tive stress can also evoke activation of this process. 
Taking all of the above mentioned aspects into the 
consideration, the results of our study at this point 
are inconsistent with the existing publications. We 
showed only slightly higher DNA fragmentation index 
in RT and slightly lower DNA fragmentation index in 
RCT patients, but we did not observed any statistical 
significance. We assumed that the reason is the fact 
that in most studies [18, 38–40] control population 
consisted of donors whose sperm parameters meet 
WHO criteria. In our study, we included donors whose 
semen not only met the WHO criteria but also had 
a population distribution similar to that of male factor, 
what probably had influenced our results. The pre-
sented results clearly point out that the semen of RT 
carriers contained fewer spermatozoa, had impaired 
motility and lowered vitality. The risks of passing RT 
chromosomal rearrangements to the next generation 
put emphasis on the importance of careful evaluation 
of semen. Carriers of mainly RT but also RCT have 
an increased risk of not only poorer semen quality but 
also infertility, repeated miscarriages and conception 
of offspring with unbalanced karyotypes. Therefore 
thorough semen analysis combined with karyotyping 
should be considered as part of genetic counseling. 
Such genetic counseling should be an important part 
of the infertility treatment process that would lead 
to improvement of outcomes for patients who are 
translocation carriers.
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